Correlates of reactive hyperemic index in men and postmenopausal women

Vascular Medicine (United Kingdom)

Volumn 18, Issue 6, 2013, Pages 340-346

  Carnovale, Valérie ^a   Paradis, Marie Eve ^a   Gigleux, Iris ^a   Ramprasath, Vanu R ^b   Couture, Patrick ^a   Jones, Peter J ^b   Lamarche, Benoît ^a   Couillard, Charles ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

digital reactive hyperemic index; endothelial dysfunction; menopause; sex differences

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BLOOD VESSEL PARAMETERS; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; METABOLIC SYNDROME X; POSTMENOPAUSE; PRIORITY JOURNAL; REACTIVE HYPEREMIC INDEX; SEX DIFFERENCE; SPHYGMOMANOMETER; TONOMETER;

DIGITAL REACTIVE HYPEREMIC INDEX; ENDOTHELIAL DYSFUNCTION; MENOPAUSE; SEX DIFFERENCES;

ADULT; AGED; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPEREMIA; INFLAMMATION; MALE; MANOMETRY; METABOLIC SYNDROME X; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS; SEX CHARACTERISTICS;

EID: 84889848973     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X13507975     Document Type: Article

References (41)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999 ; 340: 115-126
2. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 ; 285: 2486-2497
3. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation. 1997 ; 95: 252-264
4. Vitale C, Mendelsohn ME, Rosano GM. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol. 2009 ; 6: 532-542
5. Mulvagh SL, Behrenbeck T, Lahr BA, et al. Endothelial function and cardiovascular risk stratification in menopausal women. Climacteric. 2010 ; 13: 45-54
6. Mcveigh GE, Cohn JN. Endothelial dysfunction and the metabolic syndrome. Curr Diab Rep. 2003 ; 3: 87-92
7. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management. Nutr Metab Cardiovasc Dis. 2010 ; 20: 140-146
8. Skaug EA, Aspenes ST, Oldervoll L, et al. Age and gender differences of endothelial function in 4739 healthy adults: the HUNT3 Fitness Study. Eur J Prev Cardiol. 2013 ; 20: 531-540
9. Patel AR, Kuvin JT, Sliney KA, et al. Gender-based differences in brachial artery flow-mediated vasodilation as an indicator of significant coronary artery disease. Am J Cardiol. 2005 ; 96: 1223-1226
10. Heffernan KS, Karas RH, Mooney PJ, Patel AR, Kuvin JT. Pulse wave amplitude is associated with brachial artery diameter: implications for gender differences in microvascular function. Vasc Med. 2009 ; 15: 39-45
11. Bonetti PO, Pumper GM, Higano ST, Holmes DR, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004 ; 44: 2137-2141
12. Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation. 2008 ; 117: 2467-2474
13. Gupta AK, Ravussin E, Johannsen DL, Stull AJ, Cefalu WT, Johnson WD. Endothelial dysfunction: an early cardiovascular risk marker in asymptomatic obese individuals with prediabetes. Br J Med Med Res. 2012 ; 2: 413-423
14. Wilson PW, D'agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998 ; 97: 1837-1847
15. Van Der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: a practical guide. Int J Obes. 1993 ; 17: 187-196
16. Moorjani S, Dupont A, Labrie F, et al. Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism. 1987 ; 36: 244-250
17. Gillingham LG, Harris-Janz S, Jones PJ. Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids. 2011 ; 46: 209-228
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 ; 18: 499-502
19. Desbuquois B, Aurbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab. 1971 ; 33: 732-738
20. Richterich R, Dauwalder H. Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method. Schweiz Med Wochenscher. 1971 ; 101: 615-618
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 ; 28: 412-419
22. Syvanen K, Korhonen P, Partanen A, Aarnio P. Endothelial function in a cardiovascular risk population with borderline ankle-brachial index. Vasc Health Risk Manag. 2011 ; 7: 97-101
23. Ohno Y, Hashiguchi T, Maenosono R, et al. The diagnostic value of endothelial function as a potential sensor of fatigue in health. Vasc Health Risk Manag. 2010 ; 6: 135-144
24. Bacon SL, Lavoie KL, Arsenault A, et al. The research on endothelial function in women and men at risk for cardiovascular disease (REWARD) study: methodology. BMC Cardiovasc Disord. 2011 ; 11: 50
25. Mccue MC, Marlatt KL, Kelly AS, Steinberger J, Dengel DR. Evaluation of gender differences in endothelium-independent dilation using peripheral arterial tonometry. Clin Physiol Funct Imaging. 2012 ; 32: 94-98
26. Mercuro G, Deidda M, Piras A, Dessalvi CC, Maffei S, Rosano GM. Gender determinants of cardiovascular risk factors and diseases. J Cardiovasc Med. 2010 ; 11: 207-220
27. Villablanca AC, Jayachandran M, Banka C. Atherosclerosis and sex hormones: current concepts. Clin Sci (Lond). 2010 ; 119: 493-513
28. Mueck AO. Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone. Climacteric. 2012 ; 15: 11-17
29. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994 ; 24: 1468-1474
30. Benjamin EJ, Larson MG, Keyes MJ, et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation. 2004 ; 109: 613-619
31. Pulerwitz T, Grahame-Clarke C, Rodriguez CJ, et al. Association of increased body mass index and impaired endothelial function among Hispanic women. Am J Cardiol. 2006 ; 97: 68-70
32. Brook RD, Bard RL, Rubenfire M, Ridker PM, Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol. 2001 ; 88: 1264-1269
33. Suzuki T, Hirata K, Elkind MS, et al. Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS). Am Heart J. 2008 ; 156: 405-410
34. Li J, Flammer AJ, Lennon RJ, et al. Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function. Mayo Clin Proc. 2012 ; 87: 968-975
35. Vykoukal D, Davies MG. Vascular biology of metabolic syndrome. J Vasc Surg. 2011 ; 54: 819-831
36. Patvardhan E, Heffernan KS, Ruan J, et al. Augmentation index derived from peripheral arterial tonometry correlates with cardiovascular risk factors. Cardiol Res Pract. 2011 ; 2011: 253758
37. Blanco-Colio LM, Martin-Ventura JL, De Teresa E, et al. Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration. Am Heart J. 2007 ; 153: 881-888
38. Kuvin JT, Patel AR, Sliney KA, et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J. 2003 ; 146: 168-174
39. Allan RB, Delaney CL, Miller MD, Spark JI. A comparison of flow-mediated dilatation and peripheral artery tonometry for measurement of endothelial function in healthy individuals and patients with peripheral arterial disease. Eur J Vasc Endovasc Surg. 2013 ; 45: 263-269
40. Martin BJ, Gurtu V, Chan S, Anderson TJ. The relationship between peripheral arterial tonometry and classic measures of endothelial function. Vasc Med. 2013 ; 18: 13-18
41. Hamburg NM, Benjamin EJ. Assessment of endothelial function using digital pulse amplitude tonometry. Trends Cardiovasc Med. 2009 ; 19: 6-11